Abstract:Background Biliary atresia (BA) is the most common form of severe neonatal obstructive jaundice. The etiology and pathogenesis of BA are multifactorial, and different factors may interact to produce heterogeneous pathological features and clinical outcomes. Despite different pathological features, all patients received the same treatment strategy. This study performed integrative clustering analysis based on multiple high-throughput datasets to identify the molecular subtypes of BA and provide a new treatment strategy for personalized treatment of the different subtypes of BA. Methods The RNA sequence dataset GSE122340 in the Gene Expression Omnibus (GEO) database was downloaded; 31 BA and 20 control normal liver tissues were collected at our center for transcriptome sequencing, and clinical and follow-up data of BA patients were available. Molecular subtypes were identified using integrated unsupervised cluster analysis involving gene expression, biliary fibrosis, and immune enrichment scores based on the transcriptome dataset, and the results were validated using independent datasets. Results Based on the results of the integrated unsupervised clustering analysis, four molecular subtypes were identified: autoimmune, inflammatory, virus infection-related, and oxidative stress. The autoimmune subtype with a moderate prognosis was dominated by autoimmune responses and morphogenesis, such as the Fc-gamma receptor and Wnt signaling pathway. The biological process of the inflammatory subtype was mainly the inflammatory response, with the best prognosis, youngest age at surgery, and lowest liver stiffness. The virus infection-related subtype had the worst prognosis and was enriched for a variety of biological processes such as viral infection, immunity, anatomical morphogenesis, and epithelial mesenchymal transition. The oxidative stress subtype was characterized by the activation of oxidative stress and various metabolic pathways and had a poor prognosis. The above results were verified independently in the validation sets. Conclusions This study identified four molecular subtypes of BA with distinct prognosis and biological processes. According to the pathological characteristics of the different subtypes, individualized perioperative and preoperative treatment may be a new strategy to improve the prognosis of BA.

Current Understanding in the Clinical Characteristics and Molecular Mechanisms in Different Subtypes of Biliary Atresia

Identifying and validating molecular subtypes of biliary atresia using multiple high-throughput data integration analysis

The Aberrant Expression of HLA-DR in Intrahepatic Bile Ducts in Patients with Biliary Atresia: an Immunohistochemistry and Immune Electron Microscopy Study.

Advanced Therapies for Congenital Biliary Tract Malformation: from Bench to Bedside

Unsupervised Clustering Reveals Distinct Subtypes of Biliary Atresia Based on Immune Cell Types and Gene Expression

Metabonomics Reveals Metabolite Changes in Biliary Atresia Infants

Clinical Characteristics Surgical Treatment and Outcome of Biliary Atresia

Biliary atresia: the development, pathological features, and classification of the bile duct

Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia

Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century

Altered T-Cell Receptor β-Chain and Lactate Dehydrogenase Are Associated With the Immune Pathogenesis of Biliary Atresia

Immune Characteristics in Biliary Atresia Based on Immune Genes and Immune Cell Infiltration

Liver transplantation for biliary atresia: A nationwide investigation from 1996 to 2013 in mainland China.

Systems Analysis of Biliary Atresia Through Integration of High-Throughput Biological Data

Progress in Biomarkers Related to Biliary Atresia

Distinct Plasma Bile Acid Profiles of Biliary Atresia and Neonatal Hepatitis Syndrome

Biliary atresia: the role of gut microbiome, and microbial metabolites

Upregulation of High Mobility Group Box 1 May Contribute to the Pathogenesis of Biliary Atresia.

Immunologic Regulations in the Pathogenesis of Biliary Atresia and Hepatic Fibrosis

Genome-Wide Association Study Identifies A Susceptibility Locus for Biliary Atresia on 10Q24.2

Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care